Anti-obesity drugs will have a lasting influence on the food market, General Mills CEO Jeff Harmening told analysts at the Consumer Analyst Group of New York onference in Orlando last week
When you take a GLP-1 medication, it activates the same receptors in your body that GLP-1 naturally would
This occurs when the body retains excess fluid, leading to swelling in the extremities, particularly the hands, feet, and ankles
5-8 In this regard, it is well recognised that the secretion and action of GIP and GLP-1 is disturbed in obesity and T2D, 5-10,16-18 which could also directly impact skeletal health
In the landmark, large clinical studies of both semaglutide and tirzepatide for weight loss, participants took 1.7 or 2.4 mg of semaglutide and 5, 10, or 15 mg of tirzepatide
A placebo-controlled trial of the classic wellness drip, the Myers cocktail, found no statistically significant benefit over placebo in the studys primary outcome, a finding worth knowing before paying for any generic wellness infusion, and even in critically ill patients, a large randomized trial found that high-dose intravenous vitamin C did not significantly improve the outcomes it was expected to, which cautions against extrapolating dramatic benefits to healthy wellness drips